Venus Concept Receives Clearance by U.S. Food and Drug Administration for Venus Versa™ for over 20 Common Clinical Indications by longitudeadmin | Mar 24, 2016 | Portfolio News
InfaCare Pharmaceutical Announces the Successful Completion of its Phase IIB Multicenter development program for Stannsoporfin by Seini Moimoi | Mar 24, 2016 | Portfolio News
Collegium Reports 2015 Financial Results and Provides Corporate Update by longitudeadmin | Mar 15, 2016 | Portfolio News
Rapid Micro Biosystems Appoints Natale “Nat” Ricciardi to Board of Directors by longitudeadmin | Mar 15, 2016 | Uncategorized
Aimmune Therapeutics Announces Phase 2 Follow-On Study of AR101 for the Treatment of Peanut Allergy Demonstrated Increased Desensitization and Improved Tolerability with Low-Dose Maintenance by longitudeadmin | Mar 6, 2016 | Portfolio News
